Paul Keckley, author of the highly respected healthcare-focused The Keckley Report, recently asked in his weekly column whether private equity is the solution or the problem in healthcare.
It may well be a combination of both. But one thing for sure is that private equity is very likely to remain a significant presence in U.S. healthcare and could become even more ubiquitous as investors look to new technology, including artificial intelligence, to aid in patient needs at the same time as boosting their returns.
First, though, some of the not-so-good side of private equity in healthcare.
Private equity players can have a reputation for decreasing the quality of care and patient safety at the same time as increasing costs. Peer-reviewed studies, as well as industry-sponsored ones, have consistently established such a causal relat …